Biomedical applications of collagen

International Journal of Pharmaceutics

Volumn 221, Issue 1-2, 2001, Pages 1-22

  Lee, Chi H ^a   Singla, Anuj ^a   Lee, Yugyung ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Biomaterial; Collagen; Drug protein gene delivery; Tissue engineering

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; BIOMATERIAL; CHOLINERGIC RECEPTOR STIMULATING AGENT; COLLAGEN; CYCLOSPORIN; FLUOROURACIL; GENTAMICIN; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; INTERLEUKIN 2; LIPOSOME; LYSOZYME; MINOCYCLINE; NANOPARTICLE; NETILMICIN; OFLOXACIN; PILOCARPINE; PLASMID DNA; POLYMYXIN B; STEROID; TETRACYCLINE; TOBRAMYCIN; TRIFLURIDINE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ANTIGENICITY; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; BIOENGINEERING; BOVINE SPONGIFORM ENCEPHALOPATHY; BURN; CALCIFICATION; CELL CULTURE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMBEDDING; GEL; GENE TARGETING; HUMAN; MINERALIZATION; NONHUMAN; OPHTHALMOLOGY; PRIORITY JOURNAL; PROSTHESIS; PROTEIN TRANSPORT; SAFETY; SKIN TRANSPLANTATION; SPONGE; SUSTAINED DRUG RELEASE; WOUND;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMEDICAL ENGINEERING; BURNS; COLLAGEN; DRUG DELIVERY SYSTEMS; HUMANS;

EID: 0035912971     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00691-3     Document Type: Article

References (202)

1. Evaluation of the porcine intestinal collagen layer as a biomaterial
2. Intrathecal delivery of CNTF using encapsulated genetically modified xenogenic cells in amyotrophic lateral sclerosis
3. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - An alternative approach to somatic gene therapy
4. Enhanced short-term plasmid transfection of filtration surgery tissues
5. Use of collagen shields as a surgical adjunct
6. Efficacy of tobramycin - Soaked collagen shield vs. tobramycin eyedrop loaden dose for sustained experimental Pseudomonas aeruginosa induced keratitis in rabbits
7. Tissue-engineered human skin substitutes developed from collagen populated hydrated gels: Clinical and fundamental applications
8. The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation
9. Bioartificial materials based on collagen: 1. Collagen cross-linking with gaseous glutaraldehyde
10. Systemic delivery of recombinant proteins by genetically modified myoblasts
11. Collagen shields and intraocular drug delivery: Concentration of gentamicin in the aqueous and vitreous of a rabbit eye after lensectomy and vitrectomy
12. The reconstitution of living skin
13. Efficiency of nanoparticles as a carrier system for antiviral agents in human monocytes/macrophages in vitro
14. Collagen: A review
15. Collagen microparticles: Carriers for glucocorticosteroids
16. Soluble gentamycin ophthalmic inserts as a drug delivery system
17. Skin substitutes from cultured cells and collagen-GAG polymers
18. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes
19. Biotinylation of implantable collagen for drug delivery
20. Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds
21. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns
22. Some mechanical property considerations of reconstituted collagen for drug release supports
23. Immunoisolation in somatic cell gene therapy
24. Use of absorbable collagen for hemostasis in general surgical patients
25. The structure and function of connective and skeletal tissue
26. A new topical hemostatic agent in gynecological surgery
27. Surgical Catgut: He myth of allergy
28. Blends of synthetic and natural polymers as drug delivery systems for growth hormone
29. Cyclosporin-containing collagen shields suppress corneal allograft rejection
30. Three dimensional energy-minimized model of human type II smith collagen microfibrill
31. Collagen-based biomaterials as 3D scaffold for cell cultures: Applications for tissue engineering and gene therapy
32. Collagen sponge as vaginal contraceptive barrier: Critical summary of seven years of research
33. Collagen fibers as a temporary scaffold for replacement of ACL in goats
34. Intestine submucosa and polypropylene mesh for abdominal wall repair in dogs
35. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans
36. Gelatin nanoparticles by two step desolvation, a new preparation method, surface modifications and cell uptake
37. Age-related thermal stability and susceptibility to proteolysis of rat bone collagen
38. Packaging and delivery of bone induction factors in a collagenous implant
39. Biomaterials in functional reconstruction
40. Collagen - Based wound dressing effects of hyaluronic acid and fibronectin on wound healing
41. Collagen shields delivery of netilmicin: A study of ocular pharmacokinetics
42. In vitro retinoid binding and release from a collagen sponge material in a simulated intravaginal environment
43. Reconstituted collagen nanoparticles, a novel drug carrier delivery system
44. Gelatin behavior in dilute aqueous solution: Designing a nanoparticulate formulation
45. Determination of tablet strength by diametrical compression test
46. Gene transfer into respiratory epithelial cells by targetting the polymeric immunoglobulin receptor
47. Further evaluation of collagen shields as a delivery sytem for 5-fluoruracil: Histopathological observations
48. Coating liposomes with collagen (Mr 50 000) increases uptake into liver
49. Device drug delivery to the eye
50. Collagen-biomaterial for drug delivery
51. Novel delivery system for proteins using collagen as a carrier material: The minipellet
52. Protein release from collagen matrices
53. Collagen as a delivery system for hydrophobic drugs: Studies with cyclosporinee
54. Development of a skin model based on insoluble fibrillar collagen
55. Mechanisms of stiffening and strengthening in media equivalents fabricated using glycation
56. Mechanical evaluation and design of a multilayered collagenous repair
57. Effect of chemical modifications on the susceptibility of collagen to proteolysis. II. Dehydrothermal crosslinking
58. Impregnation of collagen corneal shields with liposomes: Uptake and release of hydrophilic and lipophilic marker substances
59. Collagen shield delivery of trifluorothymidine
60. Biological functions of collagen
61. Collagen
62. Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice
63. Collagen corneal shields - An important therapeutic modality
64. Long-term production and delivery of human growth hormone in vivo
65. Treatment of experimental pseudomonas keratitis using collagen shields containing tobramycin
66. Remodeling of an acellular collagen graft into a physiologically responsive neovessel
67. Collagen shield enhancement of topical dexamethasone penetration
68. Editorial: Collagen-based
69. In vivo biocompatibility of collagen-poly(hydroxyethyl methacrylate) hydrogels
70. Solid tumour chemotherapy using implantable collagen-poly (HEMA) hydrogel containing 5-fluorouracil
71. Repair of articular cartilage defects with cultured chondrocytes in Atelocollagen gel. Comparison with cultured chondrocytes in suspension
72. Collagen shield symposium
73. Collagen based drug delivery and artificial tears
74. Tissue engineering and cell populated collagen matrices
75. Bone-inductive efficacy of recombinant human bone morphogenetic protein-2 expressed in Escherichia coli: An experimental study in rat mandibular defects
76. Clinical usefulness of crosslinked N-telopeptide of type I collagen as a bone metastatic marker in patients with prostate cancer: Comparison with serum PICP, PINP and ICTP
77. BNDF atelocollagen mini-pellet accelerates facial nerve regeneration
78. A new type of biomaterial for artificial skin: Dehydrothermally cross-linked composites of fibrillar and denatured collagens
79. Effect of collagen cross-linking in collagen corneal shields on occular drug delivery
80. Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors
81. The efficacy of collagen dermis membrane and fibrin on cultured epidermal graft using an athymic mouse model
82. New polymers in drug delivery
83. New directions in the optimization of ocular drug delivery
84. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: Biochemical and biophysical mechanisms
85. New artificial connective matrix-like structure made of elastin solubilized peptides and collagens: Elaboration, biochemical and structural properties
86. New preparation and microstructure of the EndoPatch elastin-collagen containing glycosaminoglycans
87. Dermal wound repair: Role of collagen matrix implants and synthetic polymer dressings
88. Noncross-linked collagen discs and cross-linked collagen shields in the delivery of gentamicin to rabbit eyes
89. Expression of human factor IX by microencapsulated recombinant fibroblasts
90. Ectopic induction of cartilage and bone by water soluble proteins from bovine bone using a collagenous delivery vehicle
91. Microstructure and release characteristics of the minipellet, a collagen based drug delivery system for controlled release of protein drugs
92. Effects of fibroblasts and basic fibroblast growth factor on facilitation of dermal wound healing by type I collagen matrices
93. Therapeutic and protective properties of the corneal shield
94. Nanoparticles-a new colloidal drug delivery system
95. In vitro evaluation of vascular permeability to contrast media using cultured endothelial cell monolayers
96. Development of an interleukin-2 slow delivery system
97. An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants
98. Mechanical properties of implantable biomaterials
99. The use of collagen shields impregnated with amphotericin B to treat aspergillus keratomycosis
100. Collagen shields impregnated with gentamicin-dexamethason as a potential drug delivery device
101. Clinical observation on use of an extrude collagen suture
102. Subgingival administration of tetracycline on a collagen film
103. Application of a local drug delivery system to periodontal therapy: I. Development of collagen preparations with immmobilized tetracycline
104. Effects of ultraviolet irradiation on native and telopeptide-poor collagen
105. Collagen engineering for biomaterial use
106. Collagen shields
107. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts
108. Continuous systemic secretion of lysosomal enzyme by genetically-modified mouse skin fibroblasts
109. Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs
110. Solid lipid nanoparticles for controlled drug delivery-a review of the state of the art
111. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons
112. Complexation of basic fibroblast growth factor with gelatin
113. Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone
114. Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum
115. Collagen shield heparin delivery for prevention of postoperative fibrin
116. Ultrastructural study of direct bone formation induced by BMPs-collagen complex implanted into an ectopic site
117. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres
118. Denatured thiolated collagen. II. Crosslinking by oxidation
119. Molecular structures and functions of collagen
120. Bioprosthesis derived from crosslinked and chemically modified collagenous tissue
121. Use of collagen corneal shields versus soft contact lenses to enhance penetration of topical tobramycin
122. New Delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: The Minipellet
123. In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix
124. Collagen: Its place in the medical device industry
125. Effect of collagen on liposome permeability
126. A corneal lens/shield system to promote postoperative corneal epithelial healing
127. Type I atelocollagen grafting onto ozone-treated polyurethane films: Cell attachment, proliferation, and collagen synthesis
128. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia
129. Use of the acyl azide method for crosslinking collagen rich tissues such as pericardium
130. Collagen shield delivery of gentamicin and vancomycin
131. Molecular and aggregate structures of the collagens
132. Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields
133. Pilocarpine therapy with soft contact lenses
134. Clinical uses of collagen shields
135. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy
136. Mechanical loading regulates protease production by fibroblasts in three dimensional collagen substrates
137. Refinement of the structure of collagen
138. Recent Developments of Collagen-based materials for medical applications and drug delivery systems
139. Effect of crosslinking agent on the release of an aqueous marker from liposomes sequestered in collagen and chitosan gels
140. Morphogenesis and tissue engineering of bone and cartilage: Inductive signals, stem cells, and biomimetic biomaterials
141. The collagen shield: A new vehicle for delivery of cyclosporine A to the eye
142. Treatment of vocal fold immobility by glutaraldehyde-crosslinked collagen injection: Long term results
143. The effect of collagen shields on rabbit corneal re-epithelization after chemical debridement
144. Collagen as matrix for neo-organ formation by gene-transfected fibroblasts
145. Effect of Collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro
146. Collagen microparticles: Preparation and properties
147. The enhancement of cellular infiltration and vascularization of a collagenous dermal implant in the rat by platelet-derived growth factor BB
148. Collagen as a vehicle for drug delivery
149. Prolonged resorption of collagen sponges: Vapor-phase treatment with formaldehyde
150. An injectable sustained release drug delivery system markedly enhances intratumoral retention of C14-fluorouracil in murine fibro sarcomas
151. Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat public symphysis
152. High performance biomaterials
153. Microdialysis assessment of microfibrous collagen containing a p-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etopocide
154. Use of collagen corneal shields in the treatment of bacterial keratitis
155. Collagen corneal shields enhance penetration of topical prednisolone acetate
156. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants
157. Antimineralization treatments for bioprosthetic heart valves: Assessment of efficacy and safety
158. Collagen shield delivery of amphotericin B
159. A new type of surgical adhesive made from porcine collagen and polyglutamic acid
160. Retinoic acid enhances the effect of collagen on bone union, following induced non-union defect in guinea pig ulna
161. Effect of collagen shield on cat corneal epithelial wound healing
162. Treatment of urinary incontinence by the periurethal implantation of glutaraldehyde crosslinked collagen
163. Collagen, elastin and glycosaminoglycans in aortic aneurysms
164. Local treatment of bone and soft tissue infections with the collagen gentamicin sponge
165. Collagen gels: Design for vitreous replacement
166. Attachment of peptide growth factors to implantable collagen
167. Behavior of osteoblasts on a type I atelocollagen grafted ozone oxidized poly L-lactic acid membrane
168. Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice
169. Long-term follow-up study of artificial dermis composed of outer silicone layer and inner collagen sponge
170. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein
171. New Formulations of bioactive materials
172. Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine supplement gene therapy
173. Collagen shield delivery of ofloxacin to the human eye
174. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: Development and in vitro evaluations
175. Immunology of the collagens
176. In vitro effects of different formulations of bovine collagen on cultured human skin
177. The chemistry and structure of collagen
178. Kinetic study of collagen fixation with polyepoxy fixatives
179. Human chondrocyte proliferation and matrix synthesis cultured in Atelocollagen gel
180. Interaction between the vitamin D receptor gene and collagen type Ialpha 1 gene in susceptibility for fracture
181. Cross linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancer
182. Collagen shield drug delivery: Therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humour
183. Tee-plasma polymerized dermal sheep collagen for the repair of abdominal wall defects
184. Comparison between plain and gentamicin containing collagen sponges in infected peritoneal cavity in rats
185. Effect of gentamicin-containing sponges on the healing of colonic anastomoses in a rat model of peritonitis
186. Calcification of cross-linked collagen-elastin membrane implants in vivo and their proposed use in bone regeneration
187. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamycin
188. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin
189. Use of hydrophilic soft lenses to increase ocular penetration of topical drugs
190. Collagen-induced platelet aggregation and release
191. Injectable collagen for augmentation of facial areas
192. Collagen shields: Efficacy, safety and comfort in the treatment of human traumatic corneal abrasion and effect on vision in healthy eyes
193. Liposome-collagen gel matrix, A novel sustained drug delivery system
194. Ocular acyclovir delivery by collagen discs: A mouse model to screen anti-viral agents
195. Mammalian collagenases
196. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix
197. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain
198. Biologically active analogues of the extracellular matrix: Artificial skin and nerves
199. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin